Purchase of TAS asssays

The contract involves the purchase of targeted amplicon sequencing (TAS) assays intended to identify and analyze various strains of Salmonella and Cronobacter contaminating powdered infant formula. This work aims to enhance the understanding of microbial contamination in this critical food product, contributing to food safety and public health. The opportunity is posted by the Food and Drug Administration under NAICS code 334516, with a focus on advanced sequencing assays. While specific details such as solicitation number, exact office location, and point of contact for contracting remain unspecified or pending assignment, the program point of contact can be reached via the provided FDA acquisition liaison email. This effort supports the FDA’s mission to safeguard consumer products through scientific evaluation and regulatory oversight.